Roswell Park Cancer Institute researchers have developed an accurate, individualized post-operative survival calculator and integrated the technology into a mobile application compatible with smartphone technology for oncologists and patients diagnosed with colon cancer.

More than two dozen clinical researchers from Roswell Park Cancer Institute will be among the more than 30,000 cancer specialists gathered in Chicago for the American Society of Clinical Oncology 51st Annual Meeting. Several teams will be presenting the findings of Roswell Park-led research to their colleagues from around the world.

The incidence of melanoma, a deadly form of skin cancer, has increased by more than 250% among children, adolescents and young adults since 1973, according to award-winning research to be presented by Roswell Park Cancer Institute at the American Society of Clinical Oncology 51st Annual Meeting in Chicago.

A collaborative team of researchers led by Alex A. Adjei, MD, PhD, FACP, of Roswell Park Cancer Institute will share results from the first clinical study of the anticancer effects of the novel agent entolimod at the American Society of Clinical Oncology’s 51st Annual Meeting in Chicago.

Roswell Park Cancer Institute opened a new specialty pharmacy dedicated to the prescription needs of cancer patients. The pharmacy, located on the first floor of the main hospital near the Sunflower Café, is designed to be a one-stop location providing patients with their oncology-related and supportive medications.

Andrew Hyland, PhD, Chair of the Department of Health Behavior at Roswell Park Cancer Institute (RPCI) is a featured speaker at the New York State Cancer Prevention Summit, Wednesday, May 20 from 7:30 a.m. to 4:45 p.m. in New York City.

Roswell Park Comprehensive Cancer Center has received $6.19 million in research grant funding, including a five-year, $2.01 million National Cancer Institute grant to Xuefang Cao, MD, PhD, Assistant Member in the Department of Immunology.